Ignacio Aldana

3.2k total citations
100 papers, 2.7k citations indexed

About

Ignacio Aldana is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ignacio Aldana has authored 100 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Organic Chemistry, 23 papers in Molecular Biology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ignacio Aldana's work include Synthesis and Biological Evaluation (64 papers), Synthesis and biological activity (35 papers) and Synthesis and Reactions of Organic Compounds (29 papers). Ignacio Aldana is often cited by papers focused on Synthesis and Biological Evaluation (64 papers), Synthesis and biological activity (35 papers) and Synthesis and Reactions of Organic Compounds (29 papers). Ignacio Aldana collaborates with scholars based in Spain, France and Colombia. Ignacio Aldana's co-authors include Antonio Monge, Silvia Pérez‐Silanes, Belén Zarranz, Andrés Jaso, Beatriz Solano, Silvia Galiano, Raquel Villar, Asunción Burguete, Saioa Ancizu and Esther Vicente and has published in prestigious journals such as Biomaterials, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ignacio Aldana

96 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ignacio Aldana Spain	34	2.2k	546	409	290	262	100	2.7k
Silvia Pérez‐Silanes Spain	32	1.7k 0.8×	454 0.8×	339 0.8×	392 1.4×	447 1.7×	83	2.2k
Maria Cecília B. V. de Souza Brazil	30	2.1k 0.9×	765 1.4×	620 1.5×	201 0.7×	221 0.8×	118	2.9k
Carlos A. de Simone Brazil	26	1.3k 0.6×	409 0.7×	710 1.7×	332 1.1×	373 1.4×	64	1.8k
Marcelo Zaldini Hernandes Brazil	26	1.2k 0.5×	696 1.3×	113 0.3×	365 1.3×	367 1.4×	71	2.3k
Juan B. Rodríguez Argentina	26	1.3k 0.6×	563 1.0×	177 0.4×	426 1.5×	699 2.7×	99	2.1k
Giuseppe Paglietti Italy	23	1.6k 0.7×	481 0.9×	105 0.3×	117 0.4×	126 0.5×	96	2.0k
Núbia Boechat Brazil	29	2.0k 0.9×	737 1.3×	87 0.2×	514 1.8×	376 1.4×	140	2.9k
Flávio da Silva Emery Brazil	22	712 0.3×	557 1.0×	480 1.2×	145 0.5×	140 0.5×	105	1.7k
Reem K. Arafa Egypt	27	1.3k 0.6×	794 1.5×	101 0.2×	141 0.5×	175 0.7×	99	2.1k
Albertina G. Moglioni Argentina	26	1.3k 0.6×	592 1.1×	79 0.2×	129 0.4×	119 0.5×	78	2.1k

Countries citing papers authored by Ignacio Aldana

Since Specialization

Citations

This map shows the geographic impact of Ignacio Aldana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Aldana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Aldana more than expected).

Fields of papers citing papers by Ignacio Aldana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Aldana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Aldana. The network helps show where Ignacio Aldana may publish in the future.

Co-authorship network of co-authors of Ignacio Aldana

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Aldana. A scholar is included among the top collaborators of Ignacio Aldana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Aldana. Ignacio Aldana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quiliano, Miguel, Sandra Bourgeade‐Delmas, Isabelle Chantal, et al.. (2020). Alsinol, an arylamino alcohol derivative active against Plasmodium, Babesia, Trypanosoma, and Leishmania: past and new outcomes. Parasitology Research. 119(10). 3503–3515. 2 indexed citations

Quiliano, Miguel, Adriana Pabón, Ernest Moles, et al.. (2018). Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery. European Journal of Medicinal Chemistry. 152. 489–514. 4 indexed citations

Bonilla-Ramírez, Leonardo, Miguel Quiliano, Jean‐François Franetich, et al.. (2018). Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies. European Journal of Medicinal Chemistry. 158. 68–81. 44 indexed citations

Quiliano, Miguel, et al.. (2017). New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity. Bioorganic & Medicinal Chemistry Letters. 27(8). 1820–1825. 35 indexed citations

Torres, Enrique, Elsa Moreno‐Viguri, Silvia Galiano, et al.. (2013). Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents. European Journal of Medicinal Chemistry. 66. 324–334. 46 indexed citations

Vicente, Esther, Raquel Villar, Silvia Pérez‐Silanes, et al.. (2011). Quinoxaline 1,4-di-N-Oxide and the Potential for Treating Tuberculosis. Infectious Disorders - Drug Targets. 11(2). 196–204. 31 indexed citations

Estevez, Yannick, Miguel Quiliano, Asunción Burguete, et al.. (2011). Trypanocidal properties, structure–activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives. Experimental Parasitology. 127(4). 745–751. 42 indexed citations

Torres, Enrique, Elsa Moreno‐Viguri, Saioa Ancizu, et al.. (2011). New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents. Bioorganic & Medicinal Chemistry Letters. 21(12). 3699–3703. 67 indexed citations

Ancizu, Saioa, Elsa Moreno‐Viguri, Beatriz Solano, et al.. (2010). New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Bioorganic & Medicinal Chemistry. 18(7). 2713–2719. 64 indexed citations

10.

Romeiro, Nelilma Correia, Gabriela Aguirre, Paola Hernández, et al.. (2008). Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates. Bioorganic & Medicinal Chemistry. 17(2). 641–652. 87 indexed citations

11.

Villar, Raquel, et al.. (2007). Derivados de 1,4-di-N-óxido de quinoxalina y enfermedades olvidadas. Anales de la Real Academia Nacional de Farmacia. 73(4). 927–946. 1 indexed citations

12.

Moreno‐Muñoz, Antonio, et al.. (2004). Synthesis and evaluation of new arylsulfonamidomethylcyclohexyl derivatives as human neuropeptide Y Y5 receptor antagonists for the treatment of obesity. European Journal of Medicinal Chemistry. 39(1). 49–58. 8 indexed citations

13.

Galiano, Silvia, et al.. (2004). Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry. 12(17). 4717–4723. 7 indexed citations

14.

Beauverger, Philippe, Marianne Rodriguez, Jean‐Paul Nicolas, et al.. (2004). Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay. Cellular Signalling. 17(4). 489–496. 2 indexed citations

15.

Galiano, Silvia, et al.. (2004). Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y5 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(3). 597–599. 14 indexed citations

16.

Zarranz, Belén, Andrés Jaso, Ignacio Aldana, & Antonio Monge. (2004). Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives. Bioorganic & Medicinal Chemistry. 12(13). 3711–3721. 87 indexed citations

17.

Aldana, Ignacio, Miguel Á. Ortega, Andrés Jaso, et al.. (2003). Antimalarial Activity of Some 7‐Chloro‐2‐quinoxalinecarbonitrile‐1,4‐di‐N‐oxide Derivatives.. ChemInform. 34(21). 8 indexed citations

18.

Aldana, Ignacio, et al.. (2002). Medición de la saturación de oxígeno y flujo espiratorio máximo como valores predictivos para la evolución de crisis asmáticas en niños. 11(1). 12–15. 1 indexed citations

19.

Margareto, Javier, et al.. (2002). Changes in UCP2, PPARγ2, and C/EBPα Gene Expression Induced by a Neuropeptide Y (NPY) Related Receptor Antagonist in Overweight Rats. Nutritional Neuroscience. 5(1). 13–17. 3 indexed citations

20.

Aguirre, Gabriela, Hugo Cerecetto, Rossanna Di Maio, et al.. (2002). Benzo[1, 2-c]1, 2, 5-oxadiazole N-Oxide Derivatives as Potential Antitrypanosomal Drugs. Structure-Activity Relationships. Part II. Archiv der Pharmazie. 335(1). 15–21. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact